evans blue has been researched along with nociceptin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Helyes, Z; Németh, J; Oroszi, G; Pintér, E; Szolcsányi, J; Thán, M | 1 |
| Chae, YJ; Grond, S; Han, X; Jang, Y; Liu, J; Mitchell, J; Moriyama, K; Pierce Palmer, P; Wang, Y; Xie, GX; Xing, Y | 1 |
2 other study(ies) available for evans blue and nociceptin
| Article | Year |
|---|---|
Inhibition of nociceptin on sensory neuropeptide release and mast cell-mediated plasma extravasation in rats.
Topics: Animals; Bradykinin; Calcitonin Gene-Related Peptide; Capsaicin; Coloring Agents; Denervation; Evans Blue; Extravasation of Diagnostic and Therapeutic Materials; Female; Hindlimb; Mast Cells; Nociceptin; Opioid Peptides; Peptides; Rats; Rats, Wistar; Somatostatin; Substance P | 1998 |
Receptor mediation and nociceptin inhibition of bradykinin-induced plasma extravasation in the knee joint of the rat.
Topics: Animals; Bradykinin; Bradykinin B1 Receptor Antagonists; Bradykinin B2 Receptor Antagonists; Calcitonin Gene-Related Peptide; Coloring Agents; Dinoprostone; Evans Blue; Histamine; Humans; Knee Joint; Male; Nociceptin; Opioid Peptides; Plasma; Rats; Rats, Sprague-Dawley; Receptor, Bradykinin B1; Receptor, Bradykinin B2; Serotonin; Signal Transduction | 2009 |